US Stock MarketDetailed Quotes

ADMA Biologics (ADMA)

Watchlist

10.490
+0.110+1.06%

Close Apr 14 15:59 ET

10.540
+0.050+0.48%

Post 19:33 ET

2.50BMarket Cap17.48P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ADMA Biologics (ADMA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-57.53%50.4M

-29.03%35.64M

-46.89%13.29M

-53.69%21.14M

-787.06%-19.68M

1,248.55%118.67M

185.37%50.22M

108.83%25.03M

853.36%45.65M

84.94%-2.22M

Net income from continuing operations

-25.67%146.93M

-55.87%49.38M

1.45%36.43M

6.72%34.22M

51.10%26.9M

800.00%197.67M

734.15%111.9M

1,299.42%35.91M

603.25%32.06M

362.28%17.81M

Operating gains losses

147.96%3.35M

-99.32%9K

27,112.50%2.18M

----

-94.88%1.35M

-94.98%1.32M

-91.40%8K

--1K

27.78%23K

Depreciation and amortization

0.63%8.1M

5.25%2.05M

4.28%2.02M

0.54%2.06M

-6.86%1.97M

-3.44%8.05M

-7.82%1.94M

-7.27%1.94M

-2.43%2.05M

3.98%2.11M

Deferred tax

113.08%11.02M

101.39%1.17M

--4.8M

--1.62M

--3.43M

---84.28M

--0

Other non cash items

-28.96%574K

-12.02%161K

-37.96%134K

-34.90%125K

-29.03%154K

-87.15%808K

-88.11%183K

-87.13%216K

-88.28%192K

-84.85%217K

Change In working capital

-652.98%-139.6M

-264.10%-22.52M

-130.03%-37.32M

-371.24%-23M

-131.46%-56.75M

-83.14%-18.54M

280.77%13.72M

-520.20%-16.22M

267.58%8.48M

-95.73%-24.52M

-Change in receivables

-380.25%-108.43M

-14,820.57%-20.76M

-39.55%-27.95M

-152.87%-10.31M

-122.58%-49.41M

-89.48%-22.58M

-96.38%141K

-469.98%-20.03M

290.99%19.51M

-101.58%-22.2M

-Change in inventory

-1,456.42%-36.23M

-725.67%-9.8M

-164.96%-5.2M

-827.62%-19.28M

59.53%-1.95M

127.75%2.67M

116.00%1.57M

699.48%8.01M

-194.24%-2.08M

-584.54%-4.83M

-Change in prepaid assets

53.51%-1.25M

-100.36%-7K

126.63%1.16M

108.63%75K

-505.24%-2.48M

-418.67%-2.68M

-6.36%1.94M

-5,961.11%-4.36M

59.88%-869K

-39.20%611K

-Change in payables and accrued expense

45.26%7.54M

-18.63%8.44M

-457.18%-5.1M

182.61%6.46M

-285.32%-2.26M

-54.33%5.19M

35.49%10.37M

1,041.60%1.43M

-249.88%-7.82M

174.92%1.22M

-Change in other current liabilities

-7.60%-1.23M

-34.35%-395K

81.56%-234K

118.60%48K

-196.01%-650K

-44.63%-1.14M

-27.83%-294K

-371.75%-1.27M

-145.71%-258K

462.03%677K

Cash from discontinued investing activities

Operating cash flow

-57.53%50.4M

-29.03%35.64M

-46.89%13.29M

-53.69%21.14M

-787.06%-19.68M

1,248.55%118.67M

185.37%50.22M

108.83%25.03M

853.36%45.65M

84.94%-2.22M

Investing cash flow

Cash flow from continuing investing activities

-155.29%-21.89M

89.96%-276K

-1,208.56%-14.37M

-6.85%-2.53M

-99.83%-4.72M

-72.15%-8.58M

-95.45%-2.75M

-45.05%-1.1M

-171.22%-2.37M

-21.44%-2.36M

Net PPE purchase and sale

-174.43%-22.58M

60.68%-1.08M

-1,260.61%-14.37M

-17.23%-2.42M

-100.30%-4.7M

-72.42%-8.23M

-130.33%-2.76M

-39.50%-1.06M

-136.93%-2.07M

-20.67%-2.35M

Net intangibles purchase and sale

9.46%-316K

-2,842.86%-192K

--0

64.88%-105K

-26.67%-19K

-66.19%-349K

103.33%7K

---42K

---299K

---15K

Net other investing changes

--1M

----

Cash from discontinued investing activities

Investing cash flow

-155.29%-21.89M

89.96%-276K

-1,208.56%-14.37M

-6.85%-2.53M

-99.83%-4.72M

-72.15%-8.58M

-95.45%-2.75M

-45.05%-1.1M

-171.22%-2.37M

-21.44%-2.36M

Financing cash flow

Cash flow from continuing financing activities

24.49%-44.02M

70.61%-9.12M

-9.26%-27.83M

113.26%48K

-392.54%-7.13M

-49.53%-58.3M

20.44%-31.03M

-6,221.88%-25.47M

-250.83%-362K

-122.62%-1.45M

Net issuance payments of debt

98.44%-938K

98.44%-469K

----

-154.23%-60M

-27.20%-30M

---30M

--0

Net common stock issuance

---31.94M

---8.9M

----

--0

----

Proceeds from stock option exercised by employees

-60.18%2.98M

-2.93%430K

-93.16%389K

523.56%2.06M

-90.18%101K

578.80%7.49M

5,437.50%443K

812.02%5.69M

-29.87%331K

--1.03M

Net other financing activities

-143.75%-14.13M

87.95%-177K

-306.48%-4.71M

-190.91%-2.02M

-191.92%-7.23M

64.86%-5.8M

90.47%-1.47M

-456.73%-1.16M

-206.64%-693K

-286.88%-2.48M

Cash from discontinued financing activities

Financing cash flow

24.49%-44.02M

70.61%-9.12M

-9.26%-27.83M

113.26%48K

-392.54%-7.13M

-49.53%-58.3M

20.44%-31.03M

-6,221.88%-25.47M

-250.83%-362K

-122.62%-1.45M

Net cash flow

Beginning cash position

100.86%103.15M

-29.20%61.39M

2.31%90.29M

58.03%71.63M

100.86%103.15M

-40.65%51.35M

16.92%86.71M

41.16%88.24M

-34.51%45.33M

-40.65%51.35M

Current changes in cash

-129.96%-15.52M

59.64%26.25M

-1,780.29%-28.9M

-56.52%18.66M

-423.01%-31.52M

247.27%51.8M

172.09%16.44M

-113.20%-1.54M

741.44%42.92M

65.20%-6.03M

End cash Position

-15.04%87.63M

-29.20%61.39M

2.31%90.29M

58.03%71.63M

100.86%103.15M

16.92%86.71M

41.16%88.24M

-34.51%45.33M

Free cash flow

-75.02%27.51M

-27.61%34.36M

-104.49%-1.08M

-57.00%18.61M

-432.64%-24.4M

2,782.88%110.1M

193.18%47.47M

113.13%23.93M

724.46%43.28M

72.52%-4.58M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-57.53%50.4M	-29.03%35.64M	-46.89%13.29M	-53.69%21.14M	-787.06%-19.68M	1,248.55%118.67M	185.37%50.22M	108.83%25.03M	853.36%45.65M	84.94%-2.22M
Net income from continuing operations	-25.67%146.93M	-55.87%49.38M	1.45%36.43M	6.72%34.22M	51.10%26.9M	800.00%197.67M	734.15%111.9M	1,299.42%35.91M	603.25%32.06M	362.28%17.81M
Operating gains losses	147.96%3.35M	-99.32%9K	27,112.50%2.18M	----	----	-94.88%1.35M	-94.98%1.32M	-91.40%8K	--1K	27.78%23K
Depreciation and amortization	0.63%8.1M	5.25%2.05M	4.28%2.02M	0.54%2.06M	-6.86%1.97M	-3.44%8.05M	-7.82%1.94M	-7.27%1.94M	-2.43%2.05M	3.98%2.11M
Deferred tax	113.08%11.02M	101.39%1.17M	--4.8M	--1.62M	--3.43M	---84.28M	---84.28M	--0	--0	--0
Other non cash items	-28.96%574K	-12.02%161K	-37.96%134K	-34.90%125K	-29.03%154K	-87.15%808K	-88.11%183K	-87.13%216K	-88.28%192K	-84.85%217K
Change In working capital	-652.98%-139.6M	-264.10%-22.52M	-130.03%-37.32M	-371.24%-23M	-131.46%-56.75M	-83.14%-18.54M	280.77%13.72M	-520.20%-16.22M	267.58%8.48M	-95.73%-24.52M
-Change in receivables	-380.25%-108.43M	-14,820.57%-20.76M	-39.55%-27.95M	-152.87%-10.31M	-122.58%-49.41M	-89.48%-22.58M	-96.38%141K	-469.98%-20.03M	290.99%19.51M	-101.58%-22.2M
-Change in inventory	-1,456.42%-36.23M	-725.67%-9.8M	-164.96%-5.2M	-827.62%-19.28M	59.53%-1.95M	127.75%2.67M	116.00%1.57M	699.48%8.01M	-194.24%-2.08M	-584.54%-4.83M
-Change in prepaid assets	53.51%-1.25M	-100.36%-7K	126.63%1.16M	108.63%75K	-505.24%-2.48M	-418.67%-2.68M	-6.36%1.94M	-5,961.11%-4.36M	59.88%-869K	-39.20%611K
-Change in payables and accrued expense	45.26%7.54M	-18.63%8.44M	-457.18%-5.1M	182.61%6.46M	-285.32%-2.26M	-54.33%5.19M	35.49%10.37M	1,041.60%1.43M	-249.88%-7.82M	174.92%1.22M
-Change in other current liabilities	-7.60%-1.23M	-34.35%-395K	81.56%-234K	118.60%48K	-196.01%-650K	-44.63%-1.14M	-27.83%-294K	-371.75%-1.27M	-145.71%-258K	462.03%677K
Cash from discontinued investing activities
Operating cash flow	-57.53%50.4M	-29.03%35.64M	-46.89%13.29M	-53.69%21.14M	-787.06%-19.68M	1,248.55%118.67M	185.37%50.22M	108.83%25.03M	853.36%45.65M	84.94%-2.22M
Investing cash flow
Cash flow from continuing investing activities	-155.29%-21.89M	89.96%-276K	-1,208.56%-14.37M	-6.85%-2.53M	-99.83%-4.72M	-72.15%-8.58M	-95.45%-2.75M	-45.05%-1.1M	-171.22%-2.37M	-21.44%-2.36M
Net PPE purchase and sale	-174.43%-22.58M	60.68%-1.08M	-1,260.61%-14.37M	-17.23%-2.42M	-100.30%-4.7M	-72.42%-8.23M	-130.33%-2.76M	-39.50%-1.06M	-136.93%-2.07M	-20.67%-2.35M
Net intangibles purchase and sale	9.46%-316K	-2,842.86%-192K	--0	64.88%-105K	-26.67%-19K	-66.19%-349K	103.33%7K	---42K	---299K	---15K
Net other investing changes	--1M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-155.29%-21.89M	89.96%-276K	-1,208.56%-14.37M	-6.85%-2.53M	-99.83%-4.72M	-72.15%-8.58M	-95.45%-2.75M	-45.05%-1.1M	-171.22%-2.37M	-21.44%-2.36M
Financing cash flow
Cash flow from continuing financing activities	24.49%-44.02M	70.61%-9.12M	-9.26%-27.83M	113.26%48K	-392.54%-7.13M	-49.53%-58.3M	20.44%-31.03M	-6,221.88%-25.47M	-250.83%-362K	-122.62%-1.45M
Net issuance payments of debt	98.44%-938K	98.44%-469K	98.44%-469K	----	----	-154.23%-60M	-27.20%-30M	---30M	--0	--0
Net common stock issuance	---31.94M	---8.9M	----	----	----	--0	--0	----	----	----
Proceeds from stock option exercised by employees	-60.18%2.98M	-2.93%430K	-93.16%389K	523.56%2.06M	-90.18%101K	578.80%7.49M	5,437.50%443K	812.02%5.69M	-29.87%331K	--1.03M
Net other financing activities	-143.75%-14.13M	87.95%-177K	-306.48%-4.71M	-190.91%-2.02M	-191.92%-7.23M	64.86%-5.8M	90.47%-1.47M	-456.73%-1.16M	-206.64%-693K	-286.88%-2.48M
Cash from discontinued financing activities
Financing cash flow	24.49%-44.02M	70.61%-9.12M	-9.26%-27.83M	113.26%48K	-392.54%-7.13M	-49.53%-58.3M	20.44%-31.03M	-6,221.88%-25.47M	-250.83%-362K	-122.62%-1.45M
Net cash flow
Beginning cash position	100.86%103.15M	-29.20%61.39M	2.31%90.29M	58.03%71.63M	100.86%103.15M	-40.65%51.35M	16.92%86.71M	41.16%88.24M	-34.51%45.33M	-40.65%51.35M
Current changes in cash	-129.96%-15.52M	59.64%26.25M	-1,780.29%-28.9M	-56.52%18.66M	-423.01%-31.52M	247.27%51.8M	172.09%16.44M	-113.20%-1.54M	741.44%42.92M	65.20%-6.03M
End cash Position	-15.04%87.63M	-15.04%87.63M	-29.20%61.39M	2.31%90.29M	58.03%71.63M	100.86%103.15M	100.86%103.15M	16.92%86.71M	41.16%88.24M	-34.51%45.33M
Free cash flow	-75.02%27.51M	-27.61%34.36M	-104.49%-1.08M	-57.00%18.61M	-432.64%-24.4M	2,782.88%110.1M	193.18%47.47M	113.13%23.93M	724.46%43.28M	72.52%-4.58M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm